Literature DB >> 25005557

hnRNP K in PU.1-containing complexes recruited at the CD11b promoter: a distinct role in modulating granulocytic and monocytic differentiation of AML-derived cells.

Ervin Nika1, Federica Brugnoli1, Manuela Piazzi2, Elisabetta Lambertini3, Silvia Grassilli1, Alberto Bavelloni4, Roberta Piva3, Silvano Capitani, Valeria Bertagnolo1.   

Abstract

PU.1 is essential for the differentiation of haemopoietic precursors and is strongly implicated in leukaemogenesis, yet the protein interactions that regulate its activity in different myeloid lineages are still largely unknown. In the present study, by combining fluorescent EMSA (electrophoretic mobility-shift assay) with MS, we reveal the presence of hnRNP K (heterogeneous nuclear ribonucleoprotein K) in molecular complexes that PU.1 forms on the CD11b promoter during the agonist-induced maturation of AML (acute myeloid leukaemia)-derived cells along both the granulocytic and the monocytic lineages. Although hnRNP K and PU.1 act synergistically during granulocytic differentiation, hnRNP K seems to have a negative effect on PU.1 activity during monocytic maturation. Since hnRNP K acts as a docking platform, integrating signal transduction pathways to nucleic acid-directed processes, it may assist PU.1 in activating or repressing transcription by recruiting lineage-specific components of the transcription machinery. It is therefore possible that hnRNP K plays a key role in the mechanisms underlying the specific targeting of protein-protein interactions identified as mediators of transcriptional activation or repression and may be responsible for the block of haemopoietic differentiation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25005557     DOI: 10.1042/BJ20140358

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  7 in total

1.  LG-362B targets PML-RARα and blocks ATRA resistance of acute promyelocytic leukemia.

Authors:  X Wang; Q Lin; F Lv; N Liu; Y Xu; M Liu; Y Chen; Z Yi
Journal:  Leukemia       Date:  2016-03-08       Impact factor: 11.528

2.  PU.1 is involved in the immune response to Aspergillus fumigatus through upregulating Dectin-1 expression.

Authors:  Min Wang; Zhicheng Liu; Chenyang Liu; Ting Wu; Feng Cai; Quan Wang; Xin Su; Yi Shi
Journal:  BMC Infect Dis       Date:  2016-06-16       Impact factor: 3.090

3.  Vav1 is necessary for PU.1 mediated upmodulation of miR-29b in acute myeloid leukaemia-derived cells.

Authors:  Federica Vezzali; Silvia Grassilli; Elisabetta Lambertini; Federica Brugnoli; Simone Patergnani; Ervin Nika; Roberta Piva; Paolo Pinton; Silvano Capitani; Valeria Bertagnolo
Journal:  J Cell Mol Med       Date:  2018-03-13       Impact factor: 5.310

Review 4.  RNA-Binding Proteins in Acute Leukemias.

Authors:  Konstantin Schuschel; Matthias Helwig; Stefan Hüttelmaier; Dirk Heckl; Jan-Henning Klusmann; Jessica I Hoell
Journal:  Int J Mol Sci       Date:  2020-05-12       Impact factor: 5.923

5.  hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing.

Authors:  Wei-Zhao Peng; Ji-Xi Liu; Chao-Feng Li; Ren Ma; Jian-Zheng Jie
Journal:  Cancer Cell Int       Date:  2019-12-12       Impact factor: 5.722

Review 6.  The Role of RNA-Binding Proteins in Hematological Malignancies.

Authors:  Pedro Aguilar-Garrido; Álvaro Otero-Sobrino; Miguel Ángel Navarro-Aguadero; María Velasco-Estévez; Miguel Gallardo
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

7.  Crosstalk between hnRNP K and SET in ATRA-induced differentiation in acute promyelocytic leukemia.

Authors:  Karina Stringhetta Padovani; Renata Nishida Goto; Lais Brigliadori Fugio; Cristiana Bernadelli Garcia; Vani Maria Alves; Maria Sol Brassesco; Lewis Joel Greene; Eduardo Magalhães Rego; Andréia Machado Leopoldino
Journal:  FEBS Open Bio       Date:  2021-06-17       Impact factor: 2.693

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.